143 related articles for article (PubMed ID: 178683)
21. The adrenomedullary and glucagon responses of hypopituitary children to insulin-induced hypoglycemia.
Voorhess ML; Jakubowski AF; MacGillivray MH
Pediatr Res; 1981 Jun; 15(6):912-5. PubMed ID: 6264374
[No Abstract] [Full Text] [Related]
22. Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution.
Blomgren J; Ekman B; Andersson PO; Arnqvist HJ
Scand J Clin Lab Invest; 2004 Apr; 64(2):132-9. PubMed ID: 15115251
[TBL] [Abstract][Full Text] [Related]
23. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
[TBL] [Abstract][Full Text] [Related]
24. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
Sverrisdóttir YB; Elam M; Caidahl K; Söderling AS; Herlitz H; Johannsson G
J Hypertens; 2003 Oct; 21(10):1905-14. PubMed ID: 14508197
[TBL] [Abstract][Full Text] [Related]
25. Counter-regulatory hormone responses to insulin-induced acute hypoglycemia in hypopituitary patients.
Garg A; Grizzle WE; Kansal PC; Stabler TV; Boots LR
Horm Metab Res; 1994 Jun; 26(6):276-82. PubMed ID: 7927190
[TBL] [Abstract][Full Text] [Related]
26. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
[TBL] [Abstract][Full Text] [Related]
27. Amino acids as substrates in children with growth hormone deficiency and hypoglycemia.
LaFranchi S; Buist NR; Jhaveri B; Klevit H
Pediatrics; 1981 Aug; 68(2):260-4. PubMed ID: 7267234
[TBL] [Abstract][Full Text] [Related]
28. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
29. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone responses following double pulse oral glucose administration in various clinical states.
Hofeldt FD; Reed JW; Forsham PH
J Clin Endocrinol Metab; 1975 Mar; 40(3):387-92. PubMed ID: 1117051
[TBL] [Abstract][Full Text] [Related]
31. Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis.
Agha A; Monson JP
Clin Endocrinol (Oxf); 2007 Apr; 66(4):459-65. PubMed ID: 17371460
[TBL] [Abstract][Full Text] [Related]
32. Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.
Schwarz JM; Mulligan K; Lee J; Lo JC; Wen M; Noor MA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2002 Feb; 87(2):942. PubMed ID: 11836345
[TBL] [Abstract][Full Text] [Related]
33. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
[TBL] [Abstract][Full Text] [Related]
34. Ketotic hypoglycemia and hypopituitarism.
Lorentz WB
Pediatrics; 1979 Mar; 63(3):414-5. PubMed ID: 220586
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone administration increases glucose production by preventing the expected decrease in glycogenolysis seen with fasting in healthy volunteers.
Ghanaat F; Tayek JA
Metabolism; 2005 May; 54(5):604-9. PubMed ID: 15877290
[TBL] [Abstract][Full Text] [Related]
36. Islet cell function and glucose homeostasis in hypopituitary dwarfism: synergism between growth hormone and cortisone.
Underwood LE; Van den Brande JL; Antony GJ; Voina SJ; Van Wyk JJ
J Pediatr; 1973 Jan; 82(1):28-37. PubMed ID: 4564577
[No Abstract] [Full Text] [Related]
37. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
Yuen KC; Dunger DB
Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
[TBL] [Abstract][Full Text] [Related]
38. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
39. Poor specificity of low growth hormone and cortisol levels during fasting hypoglycemia for the diagnoses of growth hormone deficiency and adrenal insufficiency.
Kelly A; Tang R; Becker S; Stanley CA
Pediatrics; 2008 Sep; 122(3):e522-8. PubMed ID: 18694902
[TBL] [Abstract][Full Text] [Related]
40. Hypoketonemia and age-related fasting hypoglycemia in growth hormone deficiency.
Wolfsdorf JI; Sadeghi-Nejad A; Senior B
Metabolism; 1983 May; 32(5):457-62. PubMed ID: 6341760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
